<SEC-DOCUMENT>0001764013-24-000114-index.html : 20240626
<SEC-HEADER>0001764013-24-000114.hdr.sgml : 20240626
<ACCEPTANCE-DATETIME>20240626065624
ACCESSION NUMBER:		0001764013-24-000114
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20240812
FILED AS OF DATE:		20240626
DATE AS OF CHANGE:		20240626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunovant, Inc.
		CENTRAL INDEX KEY:			0001764013
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				832771572
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38906
		FILM NUMBER:		241070593

	BUSINESS ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		917-580-3099

	MAIL ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
		DATE OF NAME CHANGE:	20190108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>imvt-20240331defproxy.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: imvt-20240331defproxy.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>immunovantinc_vxprxyxgt20x.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: immunovantinc_vxprxyxgt20x.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>immunovantinc_vxprxyxgt20xa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: immunovantinc_vxprxyxgt20xa.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>table-capvsnl2024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: table-capvsnl2024.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>table-capvstsr2024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: table-capvstsr2024.jpg

</DOCUMENT>
</SEC-DOCUMENT>